A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.
|Articles|March 5, 2008
Congress mulling whether to move human growth hormone to Schedule III
A nonprofit group concerned over short stature in kids opposes legislation now under consideration in Congress that would move human growth hormone into Schedule III of the Controlled Substances Act.
Advertisement
Should human growth hormone be classified as a Schedule III controlled substance? That's what Congress is set to vote on this week. The
Advertisement
Related to this article
Availability will vary by state, and a pharmacy professor says cost barriers can keep families from getting vaccinated.
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
The LATA trial found long-acting cabotegravir–rilpivirine is better than daily oral therapy at keeping adolescents virologically suppressed.
Brian Smith, PharmD, explains how direct-to-consumer GLP-1 pathways broaden initial access but endanger long-term patient adherence.
Pharmacists face burnout and financial strain as PBMs take big cuts, prompting urgent calls for reform to protect patient care and community pharmacies.
What pharmacy technicians say would actually make them feel seen on World Pharmacy Technician Day, and the other 364 days of the year.
The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.
Advertisement
Advertisement
Trending on Drug Topics
1
Technicians Aren't Asking for a Party
2
Indirect Comparison Links Tirzepatide to Greater Weight Loss Than Semaglutide
3
Infections Fall With Azithromycin for Unscheduled Cesarean Deliveries
4
Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
5